In this podcast, Maura Jones, PharmD, BCPS, discusses clinical practice guidelines and various medication regimens for managing cardiovascular disease risks in patients with diabetes. This was a topic she...
Peter H. Jones, MD, discussed identifying high-risk patients and targeting specific lipid therapy to reduce risk of future cardiovascular disease events.
In part 5 of our series on lipid management, Paul Jellinger, MD, MACE, highlights the importance of coronary artery calcium score as a risk factor for ASCVD and its role in diagnosis and treatment of...
He discusses his latest research on how managing lipid levels with the Wahls diet and other integrative interventions affects fatigue related to multiple sclerosis.
In this podcast, Laurence Sperling, MD, from Emory University School of Medicine, explains the newest ACC/AHA cholesterol guidelines, the top 10 take-home messages for cardiologists, and the lessons learned...
In part 4 of our series on lipid management, Paul Jellinger, MD, explains the answer to the quiz question from part 3 of the series and talks about the role of the MESA Study in the treatment of ASCVD. ...
Dr Peter Jones from Houston Methodist Hospital discusses cardiovascular disease and lipids, topics in which he is speaking about during Consultant360's Cardiometabolic Risk Summit this year.
In this podcast, Dr. Paul S. Jellinger, the chair of the writing committee, explains the new AACE/ACE Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease.
